{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SLXN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":0.703,"timestamp":1745352000000,"preClose":0.7217,"halted":0,"volume":144114,"hourTrading":{"tag":"盘前","latestPrice":0.75,"preClose":0.7156,"latestTime":"07:15 EDT","volume":1963,"amount":1476.2399938,"timestamp":1745406955977},"delay":0,"floatShares":6748593,"shares":8414615,"eps":-0.135024,"marketStatus":"Pre-Mkt","change":-0.0187,"latestTime":"04-23 07:19:19 EDT","open":0.722,"high":0.77,"low":0.6858,"amount":105684.0923895,"amplitude":0.116669,"askPrice":0.75,"askSize":100,"bidPrice":0.703,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.135024,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745415000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7156,"preHourTrading":{"tag":"盘前","latestPrice":0.75,"preClose":0.7156,"latestTime":"07:15 EDT","volume":1963,"amount":1476.2399938,"timestamp":1745406955977},"postHourTrading":{"tag":"盘后","latestPrice":0.7106,"preClose":0.703,"latestTime":"18:44 EDT","volume":6588,"amount":4685.0827,"timestamp":1745361872943},"volumeRatio":1.023561921962629},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","floatShares":6748593,"roa":"--","roe":"--","lyrEps":0.042916,"volumeRatio":1.023561921962629,"shares":8414615,"dividePrice":0,"high":0.77,"amplitude":0.116669,"preClose":0.7217,"low":0.6858,"week52Low":0.575,"pbRate":"--","week52High":122.0184,"institutionHeld":0,"latestPrice":0.703,"eps":-0.135024,"divideRate":0,"volume":144114,"delay":0,"ttmEps":-0.135024,"open":0.722,"prevYearClose":2.01,"prevWeekClose":0.75,"prevMonthClose":1.1,"prevQuarterClose":1.1,"fiveDayClose":0.8521,"twentyDayClose":1.12,"sixtyDayClose":0.6635},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SLXN\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SLXN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522794465","title":"Silexion Therapeutics announces expanded development plan for SIL204","url":"https://stock-news.laohu8.com/highlight/detail?id=2522794465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522794465?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:41","pubTimestamp":1743165681,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics (SLXN) announced an expanded development plan for its next-generation siRNA candidate, SIL204. This strategy integrates syste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/silexion-therapeutics-announces-expanded-development-plan-for-sil204?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/silexion-therapeutics-announces-expanded-development-plan-for-sil204?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLXN","BK4139","LENZ"],"gpt_icon":0},{"id":"2522576041","title":"BRIEF-Silexion Therapeutics Corp Unveils Expanded Development Plan For Sil204","url":"https://stock-news.laohu8.com/highlight/detail?id=2522576041","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522576041?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:34","pubTimestamp":1743165292,"startTime":"0","endTime":"0","summary":"BRIEF-Silexion Therapeutics Corp Unveils Expanded Development Plan For Sil204March 28  - Silexion Therapeutics Corp SLXN.O:SILEXION THERAPEUTICS CORP - UNVEILS EXPANDED DEVELOPMENT PLAN FOR SIL204 - SEC FILINGSILEXION THERAPEUTICS CORP - TO CONDUCT ADDITIONAL TOXICOLOGY AND PHARMACODYNAMIC STUDIES IN 2025Further company coverage: SLXN.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLXN"],"gpt_icon":0},{"id":"2522789576","title":"Silexion Therapeutics Corp - to Conduct Additional Toxicology and Pharmacodynamic Studies in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522789576","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522789576?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:32","pubTimestamp":1743165165,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB0Y7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SLXN"],"gpt_icon":0},{"id":"2522576223","title":"Silexion Therapeutics Corp - Unveils Expanded Development Plan for Sil204 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522576223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522576223?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:32","pubTimestamp":1743165165,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SLXN"],"gpt_icon":0}],"pageSize":4,"totalPage":16,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-29","symbol":"SLXN","defaultRemindTime":1732890600000,"type":"split","dateTimestamp":1732856400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-08-13","symbol":"SLXN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLXN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1730520000000}}}